97. Ulcerative colitis
2,269 clinical trials,   1,331 drugs   (DrugBank: 241 drugs),   114 drug target genes,   181 drug target pathways

Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01612039
(ClinicalTrials.gov)
July 20121/6/2012Safety, Efficacy, and Tolerability Study of ASP3291 in Patients With Active Ulcerative ColitisA Phase 2, Randomized, Double-Blind, Parallel, Placebo-Controlled, Proof-of-Concept Study to Assess the Efficacy, Safety, and Tolerability of ASP3291 in Patients With Active Ulcerative ColitisUlcerative ColitisDrug: ASP3291;Drug: PlaceboTelsar Pharma Inc.NULLCompleted18 Years65 YearsBoth112Phase 2United States
2NCT01320332
(ClinicalTrials.gov)
August 201015/3/2011A Study of a Single Dose of ASP3291 in Subjects With Ulcerative ColitisA Phase 1, Randomized, Double-Blind, Placebo Controlled Study to Assess the Pharmacokinetics, Safety, and Tolerability of ASP3291 Following a Single Oral Dose in Subjects With Ulcerative ColitisUlcerative ColitisDrug: ASP3291;Drug: PlaceboTelsar Pharma Inc.NULLCompleted18 Years65 YearsBoth16Phase 1United States